• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Arcturus Therapeutics Holdings Inc (NQ:ARCT)

    21.92 +0.19 (+0.87%)
    Streaming Delayed Price Updated: 9:59 AM EDT, Oct 17, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Arcturus Therapeutics Holdings Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    10 Health Care Stocks With Whale Alerts In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
    Via Investor Brand Network
    Topics Artificial Intelligence
    Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
    On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA), 
    Via Benzinga
    Topics Artificial Intelligence
    Earnings Scheduled For May 12, 2025
     
    Via Benzinga
    Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
    EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NASDAQ:SRPT),(NASDAQ:AUTL),(NASDAQ:ARCT) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence Intellectual Property
    Forecasting The Future: 5 Analyst Projections For Arcturus Therapeutics
     
    Via Benzinga
    Arcturus Therapeutics to Attend Upcoming Investor Conferences
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    Intapp Posts Better-Than-Expected Earnings, Joins Sapiens International, Arcturus Therapeutics, Gildan Activewear And Other Big Stocks Moving Higher On Wednesday
     
    Via Benzinga
    Mercury Systems Posts Better-Than-Expected Earnings, Joins Green Dot, Arcturus Therapeutics And Other Big Stocks Moving Higher On Tuesday
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    Top movers in Tuesday's session
    Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis. 
    Via Chartmill
    Arcturus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
     
    Via Benzinga
    Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Earnings Scheduled For August 11, 2025
     
    Via Benzinga
    Arcturus Therapeutics to Attend Upcoming Investor Conferences
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Expert Outlook: Arcturus Therapeutics Through The Eyes Of 5 Analysts
     
    Via Benzinga
    Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency
    From Arcturus Therapeutics
    Via Business Wire
    Arcturus Therapeutics to Attend Upcoming Investor Conferences
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Which stocks are moving before the opening bell on Tuesday?
    Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. 
    Via Chartmill
    Demystifying Arcturus Therapeutics: Insights From 7 Analyst Reviews
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Which stocks are moving after the closing bell on Monday?
    The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today. 
    Via Chartmill
    Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.